Chest
Volume 140, Issue 6, December 2011, Pages 1540-1549
Journal home page for Chest

Original Research
COPD
Patterns of Retention of Particulate Matter in Lung Tissues of Patients With COPD: Potential Role in Disease Progression

https://doi.org/10.1378/chest.10-2281Get rights and content

Background

Particulate matter (PM) is present in lung tissues of smokers and urban dwellers. This study was designed to quantify the burden of PM in different lung tissues of subjects with COPD and determine its relationship to disease severity.

Methods

Surgical lung tissue samples from nonsmokers (control subjects) were compared with those from smokers with normal spirometry and subjects in the four other categories of the GOLD (Global Initiative for Obstructive Lung Disease) classification of COPD severity using quantitative histologic techniques.

Results

PM was present in the lung parenchyma, blood vessel walls, airways, lymphoid follicles, and alveolar macrophages. The total burden of PM (volume fraction [Vv]) in all tissues of the lung was higher in smokers than nonsmokers (P < .001) and also in smokers with airflow obstruction compared with the smokers with normal spirometry (P < .01). There was an incremental increase in total PM burden with increased COPD severity that peaked in GOLD II and then trended downward in GOLD III and IV COPD. This same pattern of PM retention was also observed in alveolar walls. The total burden of PM in lung tissues correlated with a decline in FEV1/FVC as well as pack-years smoking. mRNA expression of fibrinogen (γ chain) correlated with total lung burden of PM and burden of PM in lung parenchyma (r2 = 0.22, P < .001).

Conclusions

We conclude that retained PM is widely distributed in lung tissues of subjects with COPD and that cigarette smoke exposure and airflow obstruction are associated with retention of PM in lung tissues. We attribute the downward trend in PM burden in severe COPD to either less deposition and retention or selective removal of PM containing tissues by emphysematous destruction.

Section snippets

Tissue Collection

The source of the lung tissue examined in this study has been described in detail elsewhere.28 Briefly, lung tissue from 65 patients who required lung resection either as treatment of lung cancer or in preparation for lung transplantation for advanced COPD were used. These 65 subjects include nonsmoking control subjects (n = 11) whose lungs were resected for small lung tumors, including five with carcinoids and six with carcinomas; smokers without airflow obstruction (GOLD [Global Initiative

Results

Table 1 shows the demographic data of the study population. There were no significant differences in age or smoking pack-years between the different groups. There were no statistical differences in gender distribution between groups. In the control nonsmoking group, 18% of subjects were men. Eight of the subjects had a significant occupational exposure (construction industry and mining), and these subjects were evenly distributed between groups. In three subjects no occupational exposure

Discussion

The results presented here show that inhaled PM is retained in different lung tissue compartments (even in never-smoking subjects) with the largest amount (in volume) of PM retained in alveolar walls. In all subjects, the amount of PM retention in the whole lung was significantly higher in subjects with COPD compared with subjects without COPD (Fig 2A). In addition, comparing just smokers with a similar amount of cigarette smoke exposure, PM retention was greater in those subjects with abnormal

Conclusion

The present results show that PM is retained in lung tissues in both nonsmokers and smokers, which is consistent with the contributions of both environmental and tobacco smoking sources to the PM burden in the lung. In addition, they also show alveolar walls accumulate more PM than conducting airways, blood vessels, or lymphatic tissues and that the majority of PM retained in the lung is deposited deep into the lung. There is an association between the accumulation of PM and COPD severity that

Acknowledgments

Author contributions: Mr Ling: contributed to performing the majority of the morphometric analysis and writing the first draft of the manuscript.

Dr McDonough: contributed to the tissue processing, mean linear intercept measurements, and revision of the manuscript.

Mr Gosselink: contributed to the gene expression studies and revision of the manuscript.

Dr Elliott: contributed to collecting the lung tissues, processing the tissues for storage, coordinating the patient/tissue selection process, and

References (49)

  • SR Rutgers et al.

    Ongoing airway inflammation in patients with COPD who do not currently smoke

    Thorax

    (2000)
  • T Sint et al.

    Ambient air pollution particles and the acute exacerbation of chronic obstructive pulmonary disease

    Inhal Toxicol

    (2008)
  • J Schwartz

    Short term fluctuations in air pollution and hospital admissions of the elderly for respiratory disease

    Thorax

    (1995)
  • DW Dockery et al.

    An association between air pollution and mortality in six U.S. cities

    N Engl J Med

    (1993)
  • T Schikowski et al.

    Long-term air pollution exposure and living close to busy roads are associated with COPD in women

    Respir Res

    (2005)
  • K Kiraz et al.

    Chronic pulmonary disease in rural women exposed to biomass fumes

    Clin Invest Med

    (2003)
  • S Liu et al.

    Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China

    Thorax

    (2007)
  • JC Hogg et al.

    The pathology of chronic obstructive pulmonary disease

    Annu Rev Pathol

    (2009)
  • XY Li et al.

    Free radical activity and pro-inflammatory effects of particulate air pollution (PM10) in vivo and in vitro

    Thorax

    (1996)
  • SF van Eeden et al.

    Systemic response to ambient particulate matter: relevance to chronic obstructive pulmonary disease

    Proc Am Thorac Soc

    (2005)
  • VM Keatings et al.

    Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma

    Am J Respir Crit Care Med

    (1996)
  • A Churg et al.

    Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse

    Am J Respir Crit Care Med

    (2004)
  • WG Kuschner et al.

    Dose-dependent cigarette smoking-related inflammatory responses in healthy adults

    Eur Respir J

    (1996)
  • D Morrison et al.

    Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokers

    Eur Respir J

    (1998)
  • Cited by (21)

    • Integrated metabolomics and lipidomics reveals high accumulation of polyunsaturated lysoglycerophospholipids in human lung fibroblasts exposed to fine particulate matter

      2020, Ecotoxicology and Environmental Safety
      Citation Excerpt :

      They not only provide structural support to airways but also regulate various biological functions, including wound healing, inflammation, and angiogenesis, by playing the role of a central mediator (Kendall and Feghali-Bostwick, 2014; McAnulty, 2007; Peng and Herzog, 2012; Quesnel et al., 2010). Although the first point of contact for PMs is the epithelial layer (Asgharian et al., 2014; Ling et al., 2011), several studies have shown that fine particles of up to 0.1 μm in size can rapidly reach not only the epithelial layer but also other types of cells (e.g., macrophages and fibroblasts), blood, lymph nodes, and extrapulmonary organs (Choi et al., 2010; Mohammad et al., 2013). In addition to epithelial cells, fibroblasts are well-known primary targets or end points of the genetic toxicity of diverse chromium compounds (De Flora et al., 1990).

    • Cell death pathways of particulate matter toxicity

      2017, Chemosphere
      Citation Excerpt :

      The exclusion of vital dyes (e.g. trypan blue and fast green), mitochondrial function assay (e.g. MTT or XTT assays), and enzyme activity (e.g. LDH assay) are very rapid and important techniques for the assessment of general cytotoxicity as a starting point before exploring the mechanisms further, even though these techniques cannot distinguish between types of cell death. The lungs represent one of the first sites of exposure to PM and are the sites where most of these particles are retained (Asgharian et al., 2014; Ling et al., 2011). Therefore, in the evaluation of the effects of PM exposure, epithelial lung cell lines are commonly selected.

    • Anthocyanins from Eugenia brasiliensis edible fruits as potential therapeutics for COPD treatment

      2012, Food Chemistry
      Citation Excerpt :

      Chronic obstructive pulmonary disease (COPD), a major cause of death and disability, is expected to be the third leading cause of death worldwide by 2020 (Murray & Lopez, 1997). It is characterized by progressive airflow obstruction and airway inflammation, with the major cause being cigarette smoking (Ling et al., 2011). Alveolar macrophage numbers are increased in COPD patients, and play a key role in the pathogenesis of COPD through the secretion of pro-inflammatory mediators such as chemokines and cytokines (Barnes, 2003).

    • Air pollution and COPD: GOLD 2023 committee report

      2023, European Respiratory Journal
    • Sex Hormones and Lung Inflammation

      2021, Advances in Experimental Medicine and Biology
    View all citing articles on Scopus

    Funding/Support: This work was supported by the British Columbia Lung Association, the Heart and Stroke Foundation of Canada, and the Canadian Institutes of Health Research. Dr van Eeden was supported by a scholarship from the Michael Smith Foundation for Health Research and the Canadian Institute for Health Research. He is a senior scholar with the Michael Smith Foundation for Health Research and CIHR/GSK professor in Chronic Obstructive Pulmonary Disease.

    Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).

    View full text